These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
655 related items for PubMed ID: 28764885
1. Plasma oxalate in relation to eGFR in patients with primary hyperoxaluria, enteric hyperoxaluria and urinary stone disease. Perinpam M, Enders FT, Mara KC, Vaughan LE, Mehta RA, Voskoboev N, Milliner DS, Lieske JC. Clin Biochem; 2017 Dec; 50(18):1014-1019. PubMed ID: 28764885 [Abstract] [Full Text] [Related]
3. Plasma oxalate levels in primary hyperoxaluria type I show significant intra-individual variation and do not correlate with kidney function. Hillebrand P, Hoppe B. Pediatr Nephrol; 2020 Jul; 35(7):1227-1233. PubMed ID: 32274573 [Abstract] [Full Text] [Related]
9. Plasma Oxalate as a Predictor of Kidney Function Decline in a Primary Hyperoxaluria Cohort. Shah RJ, Vaughan LE, Enders FT, Milliner DS, Lieske JC. Int J Mol Sci; 2020 May 20; 21(10):. PubMed ID: 32443777 [Abstract] [Full Text] [Related]
14. Plasma oxalate level in pediatric calcium stone formers with or without secondary hyperoxaluria. Sikora P, Beck B, Zajaczkowska M, Hoppe B. Urol Res; 2009 Apr 20; 37(2):101-5. PubMed ID: 19183975 [Abstract] [Full Text] [Related]
15. Re: Plasma Oxalate in Relation to eGFR in Patients with Primary Hyperoxaluria, Enteric Hyperoxaluria and Urinary Stone Disease. Assimos DG. J Urol; 2018 Apr 20; 199(4):887. PubMed ID: 29642351 [No Abstract] [Full Text] [Related]
16. Potential mechanisms of marked hyperoxaluria not due to primary hyperoxaluria I or II. Monico CG, Persson M, Ford GC, Rumsby G, Milliner DS. Kidney Int; 2002 Aug 20; 62(2):392-400. PubMed ID: 12110000 [Abstract] [Full Text] [Related]
17. Etiology, urine metabolic risk factors, and urine oxalate patterns in patients with significant hyperoxaluria and recurrent nephrolithiasis. Moore JP, Mauler DJ, Narang GL, Stern KL, Humphreys MR, Keddis MT. Int Urol Nephrol; 2022 Nov 20; 54(11):2819-2825. PubMed ID: 35917078 [Abstract] [Full Text] [Related]
18. Oxalate dynamics in chronic renal failure. Comparison with normal subjects and patients with primary hyperoxaluria. Morgan SH, Purkiss P, Watts RW, Mansell MA. Nephron; 1987 Nov 20; 46(3):253-7. PubMed ID: 3306417 [Abstract] [Full Text] [Related]
19. A randomised Phase I/II trial to evaluate the efficacy and safety of orally administered Oxalobacter formigenes to treat primary hyperoxaluria. Hoppe B, Niaudet P, Salomon R, Harambat J, Hulton SA, Van't Hoff W, Moochhala SH, Deschênes G, Lindner E, Sjögren A, Cochat P. Pediatr Nephrol; 2017 May 20; 32(5):781-790. PubMed ID: 27924398 [Abstract] [Full Text] [Related]
20. Dietary risk factors for hyperoxaluria in calcium oxalate stone formers. Siener R, Ebert D, Nicolay C, Hesse A. Kidney Int; 2003 Mar 20; 63(3):1037-43. PubMed ID: 12631085 [Abstract] [Full Text] [Related] Page: [Next] [New Search]